Mitochondrial ultrastructural pathology in diabetic cardiomyopathy: integrated analysis via scanning electron microscopy and 3D visualization imaging

Abstract Background Mitochondrial dysfunction plays a pivotal role in the onset and progression of diabetic cardiomyopathy (DCM). It is hypothesized that ultrastructural mitochondrial abnormalities, molecular dynamics imbalance, and bioenergetic impairments collectively contribute significantly to c...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo Wang, Linghao Dai, Haowei Liang, Jiayu He, Jiayi Zhou, Yang Guan, Hui Wang
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-025-02884-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238180762484736
author Bo Wang
Linghao Dai
Haowei Liang
Jiayu He
Jiayi Zhou
Yang Guan
Hui Wang
author_facet Bo Wang
Linghao Dai
Haowei Liang
Jiayu He
Jiayi Zhou
Yang Guan
Hui Wang
author_sort Bo Wang
collection DOAJ
description Abstract Background Mitochondrial dysfunction plays a pivotal role in the onset and progression of diabetic cardiomyopathy (DCM). It is hypothesized that ultrastructural mitochondrial abnormalities, molecular dynamics imbalance, and bioenergetic impairments collectively contribute significantly to cardiac dysfunction. Consequently, investigating mitochondrial ultrastructural changes and metabolic disturbances is crucial for elucidating the mechanistic underpinnings of DCM. Objective This study aims to comprehensively characterize alterations in mitochondrial ultrastructure and energy metabolism in DCM and examine the interplay between these two factors. Methods High glucose-treated H9c2 cardiomyocytes and DCM model mice were analyzed via scanning electron microscopy (SEM) and 3D imaging. Three-dimensional morphometric parameters—such as Length3D, Thickness3D, Width3D, Area3D, Volume3D, Anisotropy, Flatness, and Elongation—were quantified to evaluate mitochondrial architecture. At the two-dimensional (2D) level, mitochondria-associated membrane (MAM) parameters were analyzed. Further, detailed statistical analysis was conducted on mitochondrial cristae, including cristae scores, count, width, gap size, and junction widths in myocardial tissues. Mitochondrial dynamics and autophagy-related protein expression (Mfn1, Mfn2, Opa1, p-Drp1(ser616), PINK1, Parkin1) in myocardial tissues were assessed by Western blot. Mitochondrial bioenergetics were measured by ATP content, membrane potential, mtDNA copy number, SOD levels, mitochondrial Ca2+ levels, and oxidative phosphorylation (OXPHOS) activity across Complexes I–V in myocardial tissue. Additionally, the oxygen consumption rate (OCR) of viable H9c2 cells was measured using the O2k system. Results 3D reconstruction revealed key myocardial ultrastructures—including T-tubules, sarcoplasmic reticulum (SR), intercalated discs, and mitochondria—and demonstrated significant differences in mitochondrial morphology and 3D morphometric parameters across subpopulations. Under high glucose (HG) conditions, in vitro analysis showed a reduction in mitochondrial Length3D and Anisotropy in H9c2 cells, accompanied by increases in Thickness3D, Width3D, Flatness, and Elongation. HG exposure also led to an increase in the length of MAM contact sites and the MAM-to-mitochondria perimeter ratio. In vivo, the DCM group exhibited decreased 2D morphometric parameters (length, width, area, perimeter, and shape AP), as well as reductions in 3D measurements (Thickness3D, Width3D, and Volume3D) compared to controls. No significant differences were observed in Length3D, Area3D, Anisotropy, Flatness, and Elongation between groups. 3D surface analysis revealed rough mitochondrial surfaces in the DCM group, while controls displayed smooth surfaces. Control mitochondria exhibited well-aligned, well-defined cristae, whereas DCM mitochondria showed cristae dissolution, disorganized arrangements, and vacuolization within the cristae. The DCM group also had increased cristae junction width and spacing. Additionally, megamitochondria were observed in DCM samples. The DCM group showed a significant increase in MAM contact site length and MAM-to-mitochondria perimeter ratio in myocardial tissue. Molecular analysis revealed decreased expression of fusion proteins (Mfn1, Opa1) and increased levels of p-Drp1(ser616), alongside elevated autophagy markers (PINK1, Parkin1). Bioenergetic dysfunction was evident through decreased ATP production, mitochondrial membrane potential collapse (ΔΨm), reduced mtDNA copy number, decreased SOD levels, impaired activities of complexes I/III/IV/V, and diminished basal/maximal respiration, ATP-linked respiration, and spare respiratory capacity. Conversely, mitochondrial Ca2+ levels were elevated in the DCM group, along with increased proton leakage in H9c2 cells. Conclusions This study establishes a comprehensive framework linking “3D morphology–molecular regulation–metabolic dysfunction,” highlighting the synergistic interplay between mitochondrial ultrastructural remodeling and bioenergetic failure as key drivers of DCM progression. These findings provide valuable insights into DCM pathogenesis and suggest potential therapeutic targets.
format Article
id doaj-art-e1f6b7d82e254efe920ab3345ab89d2d
institution Kabale University
issn 1475-2840
language English
publishDate 2025-08-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj-art-e1f6b7d82e254efe920ab3345ab89d2d2025-08-20T04:01:42ZengBMCCardiovascular Diabetology1475-28402025-08-0124112710.1186/s12933-025-02884-5Mitochondrial ultrastructural pathology in diabetic cardiomyopathy: integrated analysis via scanning electron microscopy and 3D visualization imagingBo Wang0Linghao Dai1Haowei Liang2Jiayu He3Jiayi Zhou4Yang Guan5Hui Wang6Zhejiang Chinese Medical UniversityJinhua Academy, Zhejiang Chinese Medical UniversityFenghua District Traditional Chinese Medicine Hospital of NingboZhejiang Chinese Medical UniversityZhejiang Chinese Medical UniversityZhejiang Chinese Medical UniversityZhejiang Chinese Medical UniversityAbstract Background Mitochondrial dysfunction plays a pivotal role in the onset and progression of diabetic cardiomyopathy (DCM). It is hypothesized that ultrastructural mitochondrial abnormalities, molecular dynamics imbalance, and bioenergetic impairments collectively contribute significantly to cardiac dysfunction. Consequently, investigating mitochondrial ultrastructural changes and metabolic disturbances is crucial for elucidating the mechanistic underpinnings of DCM. Objective This study aims to comprehensively characterize alterations in mitochondrial ultrastructure and energy metabolism in DCM and examine the interplay between these two factors. Methods High glucose-treated H9c2 cardiomyocytes and DCM model mice were analyzed via scanning electron microscopy (SEM) and 3D imaging. Three-dimensional morphometric parameters—such as Length3D, Thickness3D, Width3D, Area3D, Volume3D, Anisotropy, Flatness, and Elongation—were quantified to evaluate mitochondrial architecture. At the two-dimensional (2D) level, mitochondria-associated membrane (MAM) parameters were analyzed. Further, detailed statistical analysis was conducted on mitochondrial cristae, including cristae scores, count, width, gap size, and junction widths in myocardial tissues. Mitochondrial dynamics and autophagy-related protein expression (Mfn1, Mfn2, Opa1, p-Drp1(ser616), PINK1, Parkin1) in myocardial tissues were assessed by Western blot. Mitochondrial bioenergetics were measured by ATP content, membrane potential, mtDNA copy number, SOD levels, mitochondrial Ca2+ levels, and oxidative phosphorylation (OXPHOS) activity across Complexes I–V in myocardial tissue. Additionally, the oxygen consumption rate (OCR) of viable H9c2 cells was measured using the O2k system. Results 3D reconstruction revealed key myocardial ultrastructures—including T-tubules, sarcoplasmic reticulum (SR), intercalated discs, and mitochondria—and demonstrated significant differences in mitochondrial morphology and 3D morphometric parameters across subpopulations. Under high glucose (HG) conditions, in vitro analysis showed a reduction in mitochondrial Length3D and Anisotropy in H9c2 cells, accompanied by increases in Thickness3D, Width3D, Flatness, and Elongation. HG exposure also led to an increase in the length of MAM contact sites and the MAM-to-mitochondria perimeter ratio. In vivo, the DCM group exhibited decreased 2D morphometric parameters (length, width, area, perimeter, and shape AP), as well as reductions in 3D measurements (Thickness3D, Width3D, and Volume3D) compared to controls. No significant differences were observed in Length3D, Area3D, Anisotropy, Flatness, and Elongation between groups. 3D surface analysis revealed rough mitochondrial surfaces in the DCM group, while controls displayed smooth surfaces. Control mitochondria exhibited well-aligned, well-defined cristae, whereas DCM mitochondria showed cristae dissolution, disorganized arrangements, and vacuolization within the cristae. The DCM group also had increased cristae junction width and spacing. Additionally, megamitochondria were observed in DCM samples. The DCM group showed a significant increase in MAM contact site length and MAM-to-mitochondria perimeter ratio in myocardial tissue. Molecular analysis revealed decreased expression of fusion proteins (Mfn1, Opa1) and increased levels of p-Drp1(ser616), alongside elevated autophagy markers (PINK1, Parkin1). Bioenergetic dysfunction was evident through decreased ATP production, mitochondrial membrane potential collapse (ΔΨm), reduced mtDNA copy number, decreased SOD levels, impaired activities of complexes I/III/IV/V, and diminished basal/maximal respiration, ATP-linked respiration, and spare respiratory capacity. Conversely, mitochondrial Ca2+ levels were elevated in the DCM group, along with increased proton leakage in H9c2 cells. Conclusions This study establishes a comprehensive framework linking “3D morphology–molecular regulation–metabolic dysfunction,” highlighting the synergistic interplay between mitochondrial ultrastructural remodeling and bioenergetic failure as key drivers of DCM progression. These findings provide valuable insights into DCM pathogenesis and suggest potential therapeutic targets.https://doi.org/10.1186/s12933-025-02884-5Diabetic cardiomyopathyMitochondriaUltrastructureEnergy metabolismScanning electron microscopy3D visualization imaging
spellingShingle Bo Wang
Linghao Dai
Haowei Liang
Jiayu He
Jiayi Zhou
Yang Guan
Hui Wang
Mitochondrial ultrastructural pathology in diabetic cardiomyopathy: integrated analysis via scanning electron microscopy and 3D visualization imaging
Cardiovascular Diabetology
Diabetic cardiomyopathy
Mitochondria
Ultrastructure
Energy metabolism
Scanning electron microscopy
3D visualization imaging
title Mitochondrial ultrastructural pathology in diabetic cardiomyopathy: integrated analysis via scanning electron microscopy and 3D visualization imaging
title_full Mitochondrial ultrastructural pathology in diabetic cardiomyopathy: integrated analysis via scanning electron microscopy and 3D visualization imaging
title_fullStr Mitochondrial ultrastructural pathology in diabetic cardiomyopathy: integrated analysis via scanning electron microscopy and 3D visualization imaging
title_full_unstemmed Mitochondrial ultrastructural pathology in diabetic cardiomyopathy: integrated analysis via scanning electron microscopy and 3D visualization imaging
title_short Mitochondrial ultrastructural pathology in diabetic cardiomyopathy: integrated analysis via scanning electron microscopy and 3D visualization imaging
title_sort mitochondrial ultrastructural pathology in diabetic cardiomyopathy integrated analysis via scanning electron microscopy and 3d visualization imaging
topic Diabetic cardiomyopathy
Mitochondria
Ultrastructure
Energy metabolism
Scanning electron microscopy
3D visualization imaging
url https://doi.org/10.1186/s12933-025-02884-5
work_keys_str_mv AT bowang mitochondrialultrastructuralpathologyindiabeticcardiomyopathyintegratedanalysisviascanningelectronmicroscopyand3dvisualizationimaging
AT linghaodai mitochondrialultrastructuralpathologyindiabeticcardiomyopathyintegratedanalysisviascanningelectronmicroscopyand3dvisualizationimaging
AT haoweiliang mitochondrialultrastructuralpathologyindiabeticcardiomyopathyintegratedanalysisviascanningelectronmicroscopyand3dvisualizationimaging
AT jiayuhe mitochondrialultrastructuralpathologyindiabeticcardiomyopathyintegratedanalysisviascanningelectronmicroscopyand3dvisualizationimaging
AT jiayizhou mitochondrialultrastructuralpathologyindiabeticcardiomyopathyintegratedanalysisviascanningelectronmicroscopyand3dvisualizationimaging
AT yangguan mitochondrialultrastructuralpathologyindiabeticcardiomyopathyintegratedanalysisviascanningelectronmicroscopyand3dvisualizationimaging
AT huiwang mitochondrialultrastructuralpathologyindiabeticcardiomyopathyintegratedanalysisviascanningelectronmicroscopyand3dvisualizationimaging